Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Sichuan Huiyu Pharmaceutical Co Ltd

688553
Current price
15.94 CNY +0.06 CNY (+0.38%)
Last closed 15.93 CNY
ISIN CNE100004ZT4
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange Shanghai Stock Exchange
Capitalization 7 050 454 059 CNY
Yield for 12 month +5.42 %
1Y
3Y
5Y
10Y
15Y
688553
21.11.2021 - 28.11.2021

Sichuan Huiyu Pharmaceutical Co., Ltd. research and develops, produces, and sells anti-tumor and injection drugs in China and internationally. The company offers injection drug products, such as pemetrexed disodium, methrotraxate, docetaxel, azacitidine, oxaliplatin, irinotecan hydrochloride, paclitaxel, bendamustine hydrochloride, palonosetron hydrochloride, plerixafor, levetiracetam concentrated solution, sodium valproate concentrated solution, epirubicin hydrochloride, fulvestrant, milrinone, fluorouracil, sodium thiosulfate, zoledronic acid, zoledronic acid concentrated solution, cisatracurium besylate, bortezomib, octreotide acetate, doxorubicin, and palonosetron hydrochloride. Sichuan Huiyu Pharmaceutical Co., Ltd. was incorportaed in 2010 and is headquartered in Neijiang, China. Address: Building 3, Neijiang, China, 641000

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

P/E ratio

24.9697

Dividend Yield

1.33 %

Current Year

+936 308 230 CNY

Last Year

+1 508 140 043 CNY

Current Quarter

+292 482 463 CNY

Last Quarter

+245 020 387 CNY

Current Year

+804 562 509 CNY

Last Year

+1 330 203 499 CNY

Current Quarter

+238 394 091 CNY

Last Quarter

+203 879 717 CNY

Key Figures 688553

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 153 788 671 CNY
Operating Margin TTM 15.67 %
PE Ratio 24.9697
Return On Assets TTM 1.14 %
PEG Ratio
Return On Equity TTM 7.15 %
Wall Street Target Price
Revenue TTM 1 130 934 923 CNY
Book Value 9.25 CNY
Revenue Per Share TTM
Dividend Share 0.22 CNY
Quarterly Revenue Growth YOY 53.3 %
Dividend Yield 1.33 %
Gross Profit TTM 1 680 110 526 CNY
Earnings per share 0.67 CNY
Diluted Eps TTM 0.67 CNY
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY 738.3 %
Profit Margin 24.84 %

Dividend Analytics 688553

Dividend growth over 5 years

Continuous growth

1 year

Payout Ratio 5 years average

53 %

Dividend History 688553

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 0.21
Ex Dividend Date 24.06.2024
Forward Annual Dividend Yield 1.29 %
Last Split Factor
Payout Ratio 32.27 %
Last Split Date
Dividend Date

Stock Valuation 688553

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 24.9697
Forward PE
Enterprise Value Revenue 4.4119
Price Sales TTM 6.2834
Enterprise Value EBITDA 15.3963
Price Book MRQ 1.7992

Financials 688553

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 688553

For 52 weeks

9.39 CNY 17.48 CNY
50 Day MA 11.91 CNY
Shares Short Prior Month
200 Day MA 12.81 CNY
Short Ratio
Shares Short
Short Percent